Tenofovir Monotherapy versus Tenofovir plus Lamivudine or Telbivudine Combination Therapy in Treatment of Lamivudine-Resistant Chronic Hepatitis B

Tenofovir disoproxil fumarate (TDF) monotherapy is a therapeutic option for chronic hepatitis B (CHB) patients infected with hepatitis B virus (HBV) variants resistant to lamivudine (LAM). We evaluated the antiviral efficacy and safety of TDF alone compared to those of TDF plus LAM or telbivudine (L...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Lee, Yun Bin, Jung, Eun Uk, Kim, Bo Hyun, Lee, Jeong-Hoon, Cho, Hyeki, Ahn, Hongkeun, Choi, Won-Mook, Cho, Young Youn, Lee, Minjong, Yoo, Jeong-Ju, Cho, Yuri, Lee, Dong Hyeon, Cho, Eun Ju, Yu, Su Jong, Park, Sung Jae, Kim, Yoon Jun, Park, Joong-Won, Lee, Youn Jae, Kim, Chang-Min, Yoon, Jung-Hwan, Kim, Chung Yong, Lee, Hyo-Suk
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2015
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335865/
https://ncbi.nlm.nih.gov/pubmed/25421484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04454-14
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires